Protein Kinase CK2 Inhibitors: Emerging Anticancer Therapeutic Agents?

ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)


Volume 16, 12 Issues, 2016


Download PDF Flyer




Anti-Cancer Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Cancer Agents

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 27th of 59 in Chemistry, Medicinal

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Michelle Prudhomme
Universite Blaise Pascal - C.N.R.S
Aubiere Cedex
France


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.722
5 - Year: 2.849

Protein Kinase CK2 Inhibitors: Emerging Anticancer Therapeutic Agents?



Anti-Cancer Agents in Medicinal Chemistry, 8(7): 798-806.

Author(s): Andrea Bortolato, Giorgio Cozza and Stefano Moro.

Affiliation: Molecular Modeling Section (MMS), Dipartimento di Scienze Farmaceutiche, Universita di Padova, Via Marzolo 5, I-35131 Padova, Italy.

Abstract

Protein kinase CK2 is a ubiquitous, essential, and highly pleiotropic protein kinase whose abnormally high constitutive activity is suspected to underlie its pathogenic potential in neoplasia and other diseases. A number of structurally unrelated CK2 inhibitors, tested on a variety of cells derived from tumours, including lymphomas, leukaemias, multiple myeloma and prostate carcinoma, display a proapoptotic effect which is roughly proportional to their in vitro inhibitory potency. In the present review we summarize the most recent discovery of potent and selective CK2 inhibitors and their prospective as future anticancer agents.

Keywords:

Protein kinase CK2, casein kinase 2, anticancer drugs, drug discovery.



Purchase Online Order Reprints Order Eprints Rights and Permissions




Article Details

Volume: 8
Issue Number: 7
First Page: 798
Last Page: 806
Page Count: 9
DOI: 10.2174/187152008785914761
Price: $58
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science